SMTL ID : 4wua.1

Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 3UL: N-[2-(1-piperidinyl)-5-(trifluoromethyl)phenyl]-4-pyridinecarboxamide(Non-covalent)

3UL.1: 14 residues within 4Å: Chain A: L.49, G.50, A.70, V.108, F.128, E.129, V.130, L.131, G.132, H.133, L.183, V.186, Y.190, L.194 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.49, A:A.70, A:F.128, A:L.131, A:L.183 Hydrogen bonds: A:L.131, A:G.132 Halogen bonds: A:L.131

1 x CIT: CITRIC ACID(Non-functional Binders)

CIT.2: 3 residues within 4Å: Chain A: R.261, R.264, R.307 4 PLIP interactions: 4 interactions with chain A Salt bridges: A:R.261, A:R.264, A:R.264, A:R.307

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Morooka, S. et al., Identification of a Dual Inhibitor of SRPK1 and CK2 That Attenuates Pathological Angiogenesis of Macular Degeneration in Mice. Mol.Pharmacol. (2015)

Release Date

2015-09-16

Peptides

SRSF protein kinase 1, linker, SRSF protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

SRSF protein kinase 1, linker, SRSF protein kinase 1